HC Wainwright & Co. Reiterates Buy on Rallybio, Maintains $18 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Mitchell Kapoor reiterates a Buy rating on Rallybio (NASDAQ:RLYB) and maintains an $18 price target.
June 26, 2023 | 10:07 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Mitchell Kapoor reiterates a Buy rating on Rallybio and maintains an $18 price target.
The reiterated Buy rating and maintained $18 price target by HC Wainwright & Co. analyst Mitchell Kapoor indicates a positive outlook for Rallybio's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100